Information about Octapharma (IP)
My details
*
*
*

Octapharma (IP) (SRL)

Company information

Status
Active

Enterprise number

BE0675.901.443

VAT liability
No
Established
22-05-2017
Last balance sheet year
2025
Company size
Micro 0 FTE
Principal activity
Wholesale of pharmaceutical and medical goods
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Octapharma (IP)

2025 2024 2023 2022
Profit/Loss 5,089 18,56% 4,292 19,15% 3,602 2,91% 3,501
Equity 40,621 14,32% 35,533 13,74% 31,241 13,03% 27,638
Gross margin 7,876 14,54% 6,876 18,28% 5,813 -14,16% 6,772

Publications from Octapharma (IP)

Date Publication
17-03-2025 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Registered Office - Resignations, Appointments (FR)
24-05-2017 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the enterprise number of Octapharma (IP)?
The enterprise number of Octapharma (IP) is BE 0675.901.443.
Wat is the PEPPOL ID of Octapharma (IP)?
There is no information available about the PEPPOL ID of Octapharma (IP) or the company is not yet registered on the PEPPOL network.
When was Octapharma (IP) founded?
Octapharma (IP) was founded on 22-05-2017.
What is the address of Octapharma (IP)?
The current registered office of Octapharma (IP) is located at Route de Lennik 451, 1070 Anderlecht.
When was the last time Octapharma (IP) filed their annual financial statements?
The most recent financial statements of Octapharma (IP) were filed on 10-08-2026.
How many employees does Octapharma (IP) have?
There are currently no employees working at Octapharma (IP) or no workforce information is available.
What is the annual turnover of Octapharma (IP)?
At the time of its most recent financial statements, Octapharma (IP) did not publish any turnover figures. Octapharma (IP) reported a gross margin of €7,875.83.